Jhanelle Gray MD(@JhanelleGray) 's Twitter Profileg
Jhanelle Gray MD

@JhanelleGray

Dr Jhanelle E. Gray Department Chair, Program Leader and Senior Member, Thoracic Oncology; Co-Leader, Molecular Medicine Program @MoffittNews in Tampa, FL.

ID:1401344104634765312

linkhttp://moffitt.org calendar_today06-06-2021 01:04:47

27 Tweets

525 Followers

205 Following

Lung-MAP(@LungMAP) 's Twitter Profile Photo

Your patients with new MET amplification after has progressed on osimertinib may be eligible for Lung-MAP sub-study SWOG Cancer Research Network S1900G. MET amplification found by tissue assay at a CLIA-certified lab can be used. SWOG.org/clinical-trial…

Your patients with new MET amplification after #NSCLC has progressed on osimertinib may be eligible for @LungMAP sub-study @SWOG S1900G. MET amplification found by tissue assay at a CLIA-certified lab can be used. SWOG.org/clinical-trial… #lungcancer
account_circle
IASLC(@IASLC) 's Twitter Profile Photo

We are currently accepting applications for groups of qualified members from the Europe Region to serve as Co-Chairs for taking place September 6-9, 2025 in Barcelona, Spain. Learn More and Submit Your Application before Nov. 15, 2023! bit.ly/3Qsj9ew

We are currently accepting applications for groups of qualified #IASLC members from the Europe Region to serve as Co-Chairs for #WCLC25 taking place September 6-9, 2025 in Barcelona, Spain. Learn More and Submit Your Application before Nov. 15, 2023! bit.ly/3Qsj9ew #LCSM
account_circle
Jhanelle Gray MD(@JhanelleGray) 's Twitter Profile Photo

Please look into this! Due Jan 19, 2024-Gilead’s Research Scholars Program in Solid Tumors supports independent research and researchers in Lung, Breast and Bladder cancers with $180,000 USD paid to their institution. Find out more and apply here: researchscholars.gilead.com/en/solid_tumor…

account_circle
SWOG Cancer Research Network(@SWOG) 's Twitter Profile Photo

If your patient’s has progressed on osimertinib, consider screening for Lung-MAP. If MET amplification is found, pt may be eligible for S1900G: capmatinib + osimertinib w/wo ramucirumab. Co-PI: Ross Camidge, MD, PhD CU Cancer Center SWOG.org/clinical-trial… CU Anschutz Medical Campus

If your patient’s #NSCLC has progressed on osimertinib, consider screening for @LungMAP. If MET amplification is found, pt may be eligible for S1900G: capmatinib + osimertinib w/wo ramucirumab. Co-PI: Ross Camidge, MD, PhD @CUCancerCenter SWOG.org/clinical-trial… @CUAnschutz
account_circle
SWOG Cancer Research Network(@SWOG) 's Twitter Profile Photo

Registration is now open for the SWOG Cancer Research Network Fall 2023 Group Meeting! We'll meet face-to-face at the Hyatt Regency Chicago, with many sessions also available virtually. Learn more, view the schedule, and register now to attend, at swog.org/news-events/sw… The Hope Foundation for Cancer Research

Registration is now open for the @SWOG Fall 2023 Group Meeting! We'll meet face-to-face at the Hyatt Regency Chicago, with many sessions also available virtually. Learn more, view the schedule, and register now to attend, at swog.org/news-events/sw… #SWOGonc @SupportingSWOG
account_circle
SWOG Cancer Research Network(@SWOG) 's Twitter Profile Photo

that gets worse after treatment with ( ) sometimes has new changes in the MET gene. Lung-MAP sub-study S1900G is for people with both and MET gene changes. Learn more at SWOG.org/S1900G. Or call 1-800-4-CANCER. Ask about S1900G.

#NSCLC that gets worse after treatment with #osimertinib (#Tagrisso) sometimes has new changes in the MET gene. @LungMAP sub-study S1900G is for people with both #EGFR and MET gene changes. Learn more at SWOG.org/S1900G. Or call 1-800-4-CANCER. Ask about S1900G. #lcsm
account_circle
SWOG Cancer Research Network(@SWOG) 's Twitter Profile Photo

Knowing if gene changes beyond KRAS G12C affect how sotorasib works may improve how doctors prescribe the drug for . That’s the goal of Lung-MAP S1900E. It could lead to better treatment options for patients. Visit SWOG.org/S1900E. Or call 1-800-4-CANCER. LUNGevity Foundation

Knowing if gene changes beyond KRAS G12C affect how sotorasib works may improve how doctors prescribe the drug for #NSCLC. That’s the goal of @LungMAP S1900E. It could lead to better treatment options for patients. Visit SWOG.org/S1900E. Or call 1-800-4-CANCER. @LUNGevity
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

🌟Tremendous breakthroughs were made in the treatment of in 2021.

What do these advances mean for patients? Watch @Jillfeldman4, Co-Founder of EGFR Resisters and a , share her perspective below.

🔗📰 bit.ly/LungTopAdvances

CC: OncoAlert

account_circle
Dr. Estela Rodriguez(@Latinamd) 's Twitter Profile Photo

We can all agree that comprehensive is critical for advanced NSCLC, but testing options change as new drugs are approved.

👉Do you routinely test for EGFR mutations in Stage IB-III? Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Luis E Raez Jhanelle Gray MD @americancancer

We can all agree that comprehensive #biomarkertesting is critical for advanced NSCLC, but testing options change as new drugs are approved. 👉Do you routinely test for EGFR mutations in Stage IB-III? @RManochakian @LuisERaez1 @JhanelleGray @americancancer #ECHOseries #lcsm
account_circle
Dr. Patrick Hwu(@PatrickHwuMD) 's Twitter Profile Photo

screening cuts mortality by up to 20%. But there is a huge health equity issue - less than 6% of those eligible participate. Thank you to our Moffitt Cancer Center team and Roswell Park partners for carrying this importance message to members of congress today.

#LungCancer screening cuts mortality by up to 20%. But there is a huge health equity issue - less than 6% of those eligible participate. Thank you to our @MoffittNews team and @RoswellPark partners for carrying this importance message to members of congress today. #MoffittDCFlyIn
account_circle
Dr. Patrick Hwu(@PatrickHwuMD) 's Twitter Profile Photo

Cancer impacts all of us and is a global and bipartisan issue. The Moffitt Cancer Center team was honored to meet with Danielle Carnival and the team today to discuss Moffitt’s bold initiatives to cut the cancer death rate and address cancer health disparities.

Cancer impacts all of us and is a global and bipartisan issue. The @MoffittNews team was honored to meet with @DCarnival46 and the #CancerMoonshot team today to discuss Moffitt’s bold initiatives to cut the cancer death rate and address cancer health disparities. #MoffittDCFlyIn
account_circle
Dr. Patrick Hwu(@PatrickHwuMD) 's Twitter Profile Photo

The Moffitt Cancer Center team with Col. Craig Shriver, Director, John P. Murtha Cancer Center at Walter Reed National Military Medical Center. @WRBethesda

The @MoffittNews team with Col. Craig Shriver, Director, John P. Murtha Cancer Center at Walter Reed National Military Medical Center. @WRBethesda #MoffittDCFlyIn
account_circle
Moffitt Cancer Center(@MoffittNews) 's Twitter Profile Photo

Since 2009, the CWSoftballGame has raised over $2 million for the Young Survival Coalition, a nonprofit that supports people 40 and younger who have been diagnosed with breast cancer. Moffitt Cancer Center was proud to sponsor the event and cheer on our allies in Congress! U.S. Rep. Kathy Castor

account_circle
Susan Vadaparampil(@SVadaparampil) 's Twitter Profile Photo

So happy to partner with Jhanelle Gray MD, PlatformQ Health, LUNGevity Foundation, Stand Up To Cancer to educate about clinical trials. Together we reached +18,000 individuals, but we are not done! Please share with your communities: cancercoachlive.com/cancer-clinica…

So happy to partner with @JhanelleGray, @PlatformQHealth, @LUNGevity, @SU2C to educate about clinical trials. Together we reached +18,000 individuals, but we are not done! Please share with your communities: cancercoachlive.com/cancer-clinica…
account_circle